Pulmatrix Reports Q3 2026 Results and Targets Year-End Merger Closing
Pulmatrix reported a third-quarter 2026 net loss of $1.2 million, compared with a $0.9 million loss a year earlier, as general and administrative expenses rose amid merger-related work. The company ended September with $1.4 million in cash and cash equivalents, plus $0.7 million in restricted cash…